» Articles » PMID: 28129329

Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion

Overview
Journal PLoS One
Date 2017 Jan 28
PMID 28129329
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many studies have observed space-time clustering of childhood leukemia (CL) yet few have attempted to elicit etiological clues from such clustering. We recently reported space-time clustering of CL around birth, and now aim to generate etiological hypotheses by comparing clustered and nonclustered cases. We also investigated whether the clustering resulted from many small aggregations of cases or from a few larger clusters.

Methods: We identified cases of persons born and diagnosed between 1985 and 2014 at age 0-15 years from the Swiss Childhood Cancer Registry. We determined spatial and temporal lags that maximized evidence of clustering based on the Knox test and classified cases born within these lags from another case as clustered. Using logistic regression adjusted for child population density, we determined whether clustering status was associated with age at diagnosis, immunophenotype, cytogenetic subtype, perinatal and socioeconomic characteristics, and pollution sources.

Results: Analyses included 1,282 cases of which 242 were clustered (born within 1 km and 2 years from another case). Of all investigated characteristics only the t(12;21)(p13;q22) translocation (resulting in ETV6-RUNX1 fusion) differed significantly in prevalence between clustered and nonclustered cases (40% and 25%, respectively; adjusted OR 2.54 [1.52-4.23]; p = 0.003). Spatio-temporal clustering was driven by an excess of aggregations of two or three children rather than by a few large clusters.

Conclusion: Our findings suggest ETV6-RUNX1 is associated with space-time clustering of CL and are consistent with an infection interacting with that oncogene in early life leading to clinical leukemia.

Citing Articles

Evidence of spatial clustering of childhood acute lymphoblastic leukemia cases in Greater Mexico City: report from the Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia.

Duarte-Rodriguez D, Flores-Lujano J, McNally R, Perez-Saldivar M, Jimenez-Hernandez E, Martin-Trejo J Front Oncol. 2024; 14:1304633.

PMID: 38420017 PMC: 10899509. DOI: 10.3389/fonc.2024.1304633.


Toward prevention of childhood ALL by early-life immune training.

Hauer J, Fischer U, Borkhardt A Blood. 2021; 138(16):1412-1428.

PMID: 34010407 PMC: 8532195. DOI: 10.1182/blood.2020009895.


Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.

Cobaleda C, Vicente-Duenas C, Sanchez-Garcia I Nat Rev Immunol. 2021; 21(9):570-581.

PMID: 33558682 DOI: 10.1038/s41577-021-00505-2.


Space-time clustering of childhood cancers: a systematic review and pooled analysis.

Kreis C, Doessegger E, Lupatsch J, Spycher B Eur J Epidemiol. 2018; 34(1):9-21.

PMID: 30446850 PMC: 6326085. DOI: 10.1007/s10654-018-0456-y.

References
1.
Onozuka D, Hagihara A . Spatial and temporal dynamics of influenza outbreaks. Epidemiology. 2008; 19(6):824-8. DOI: 10.1097/EDE.0b013e3181880eda. View

2.
McNally R, Alexander F, Birch J . Space-time clustering analyses of childhood acute lymphoblastic leukaemia by immunophenotype. Br J Cancer. 2002; 87(5):513-5. PMC: 2376144. DOI: 10.1038/sj.bjc.6600498. View

3.
Kinlen L . Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988; 2(8624):1323-7. DOI: 10.1016/s0140-6736(88)90867-7. View

4.
Lausten-Thomsen U, Madsen H, Vestergaard T, Hjalgrim H, Nersting J, Schmiegelow K . Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates. Blood. 2010; 117(1):186-9. DOI: 10.1182/blood-2010-05-282764. View

5.
Pui C, Carroll W, Meshinchi S, Arceci R . Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011; 29(5):551-65. PMC: 3071256. DOI: 10.1200/JCO.2010.30.7405. View